Cytovance Biologics

Exhibitor

A leading US-based biopharmaceutical contract development and manufacturing organization (CDMO), Cytovance Biologics brings over 20 years of innovation and ingenuity to international customers looking for unrivaled large molecule biologics support from protein to patient. In addition to world-class mammalian and microbial expression and cGMP manufacturing services with a 95% scale-up success rate, the Cytovance team provides fully integrated process development, analytical, and transfer services. The company's exceptional FDA audit record and 140,000+ sq. ft state-of-the-art facilities have enabled customers to produce regulatory-approved antibodies, fusion proteins, enzymes, vaccines, recombinant proteins, and others for critical medical needs.

website